We invite you to explore the links below to find out more about commercial litigation, intellectual property, mesothelioma cancer, pharmaceutical (drug) liability, product liability, toxic exposures and wrongful death!
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
NEW YORK (Reuters Health) - Adding to evidence that men with early prostate cancer can safely put off surgery, a new study finds that patients who delayed surgery by over a year had similar outcomes as those who opted for immediate treatment.
MOSCOW (Reuters) - Moscow banned night-time sales of vodka and other spirits on Wednesday, part of a nationwide drive to curb crime and disease linked with Russia's national drink.
WASHINGTON (Reuters) - The U.S. Department of Justice will continue to "aggressively pursue" pharmaceutical companies that illegally market drugs for uses that have not been approved by health regulators, a top agency official said on Wednesday.
NEW YORK (Reuters Health) - Some thirty years after authorities doled out the last dose of smallpox vaccine, the world faces another multiplying menace: monkeypox.
HONG KONG (Reuters) - Nearly 100 million children in China will be vaccinated against measles this month to help eliminate the disease, a leading cause of avoidable death and disability in developing countries, the WHO said on Wednesday.
LONDON (Reuters) - Thousands of people are putting their health and life savings at risk to travel to private clinics around the world for unproven and potentially dangerous stem cell treatments, British experts said on Tuesday.
CHICAGO (Reuters) - Women with mutations in the well-known BRCA1 or BRCA2 genes who have their breasts and ovaries removed are much more likely to survive than women who do not get preventive surgery, U.S. researchers said on Tuesday.
WASHINGTON (Reuters) - The Obama administration asked a federal judge on Tuesday to lift an injunction halting human embryonic stem cell research, saying it would irreparably harm research and cost more than 1,300 jobs.
CHICAGO (Reuters) - Women with mutations in the well-known BRCA1 or BRCA2 genes who have their breasts and ovaries removed are much more likely to survive than women who do not get preventive surgery, U.S. researchers said on Tuesday.
LONDON (Reuters) - Tens of millions of people in low and middle income countries would be pushed below the poverty line by buying common but vital medicines which are already unaffordable to hundreds of millions more, a study has found.
NEW YORK (Reuters Health) - Full-term babies born a bit on the early or late side are at higher risk of cerebral palsy, according to a new study in nearly 1.7 million Norwegian children.
CHICAGO (Reuters) - Minnesota Governor Tim Pawlenty directed state agencies on Tuesday to decline all discretionary participation in federal healthcare reform, throwing up roadblocks to President Barack Obama's goal of providing health insurance to all Americans.
LONDON (Reuters) - Thousands of people are putting their health and life savings at risk to travel to private clinics around the world for unproven and potentially dangerous stem cell treatments, British experts said on Tuesday.
NEW YORK (Reuters Health) - A new proposed diabetes test could miss millions of cases of diabetes and pre-diabetes and also over-diagnose black Americans if it was used as a screening tool, suggests a new study.
NEW YORK (Reuters Health) - Some thirty years after authorities doled out the last dose of smallpox vaccine, the world faces another multiplying menace: monkeypox.
NEW YORK (Reuters Health) - Finland's prevalence of chronic obstructive pulmonary disease (COPD), a group of serious lung diseases closely related to smoking, has held relatively steady in recent decades, a new study finds.
STOCKHOLM (Reuters) - An experimental drug from Bristol-Myers Squibb and Pfizer reduces the risk of stroke by more than half compared with aspirin, with no significant rise in major bleeding, researchers said on Tuesday.
NEW YORK (Reuters Health) - Hormone replacement therapy after menopause may interfere with the accuracy of mammograms used to screen for breast cancer -- and the risk may be greater with hormones delivered by patch or injection compared with pills, a new study finds.
WASHINGTON (Reuters) - U.S. health officials are set to rule on whether a faster-growing, genetically engineered fish is safe to eat in a decision that could deliver the first altered animal food to consumers' dinner plates.
CHICAGO (Reuters) - Two Iowa egg farms linked to a salmonella outbreak that has sickened thousands failed to follow their own safety plans, allowing rodents and other animals into poultry houses, U.S. Food and Drug Administration inspectors found.